by Amit Jain | Aug 3, 2022 | Incentive Compensation, Incentive Compensation Management, Pharmaceuticals, Quota Setting, Sales Compensation, Sales Compensation Management, sales incentives, Sales Performance Management, Uncategorized
Hey there, pharmaceutical sales operations teams! Are you ready to unlock the potential of your incentive compensation strategies and ignite a fire within your sales force? Look no further! In this blog post, we’ll explore the best practices for designing and...
by marketing | Oct 19, 2021 | Incentive Compensation, Pharmaceuticals, sales incentives
The world of sales demands a motivated set of employees. Their work can get pretty tiring and require a lot of dedication to achieve the set goals. Although there are several other ways to increase employee engagement and inject a spark of motivation...
by marketing | Oct 5, 2021 | Incentive Automation, Incentive Compensation, Medical Devices, Pharmaceuticals, Sales Incentive Solution
Many companies evaluate the performance of their sales incentive plan designs regularly on a variety of business factors, as well as their impact on salesforce morale. These types of evaluations typically mix qualitative input from salespeople, at all levels of...
by marketing | Aug 20, 2021 | Clinical Testing, Clinical Trials, Pharmaceuticals
Clinical trials are a vast domain of research with lots of areas and topics to explore. This series of blogs started with a general overview of the Clinical trials space “Clinical Trials And Their Evolution” followed by the next one...
by marketing | Jul 23, 2021 | Clinical Testing, Clinical Trials, Pharmaceuticals, Therapeutic Areas
Over the years, Clinical Trials have been carried out in various fields of research to find a remedy for diseases or research in particular therapeutic areas. Clinical trials have been one of the most researched areas in terms of medical research and...
by marketing | Jul 9, 2021 | CMS, Healthcare providers, Open Payments, Pharmaceuticals
Open Payments houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to cover recipients like physicians. The motive is to promote a more transparent and accountable health care system. However, if...
